Showing 221 - 240 results of 804 for search '"Inflammatory bowel disease"', query time: 0.09s Refine Results
  1. 221

    Serum Concentration and Chemotactic Activity of E-selectin (CD62E) in Inflammatory Bowel Disease by B. Vainerc, O. H. Nielsen

    Published 1994-01-01
    “…Because a high expression of this molecule at intestinal mucosal surfaces in inflammatory bowel disease (IBD) has been described earlier, the aim was to assess serum levels of E-selectin (sE-selectin) and to correlate it to disease activity, and further to evaluate its chemotactic properties at physiological concentrations. …”
    Get full text
    Article
  2. 222

    Interleukin-10 in the Pathophysiology of Inflammatory Bowel Disease: Increased Serum Concentrations During the Recovery Phase by Keiichi Mitsuyama, Nobuo Tomiyasu, Kosuke Takaki, Junya Masuda, Hiroshi Yamasaki, Kotaro Kuwaki, Teiko Takeda, Shigehiko Kitazaki, Osamu Tsuruta, Michio Sata

    Published 2006-01-01
    “…In conclusion, this study shows that serum IL-10 is increased during disease recovery in patients with inflammatory bowel disease, and may be a helpful marker in monitoring disease status.…”
    Get full text
    Article
  3. 223

    Severe Symptomatic Primary CMV Infection in Inflammatory Bowel Disease Patients with Low Population Seroprevalence by Catherine Rowan, Ciaran Judge, Mary D. Cannon, Garret Cullen, Hugh E. Mulcahy, Elizabeth Ryan, Cillian F. De Gascun, Glen A. Doherty

    Published 2018-01-01
    “…Cytomegalovirus disease in patients with inflammatory bowel disease is frequently the result of viral reactivation. …”
    Get full text
    Article
  4. 224

    Role of RING-Type E3 Ubiquitin Ligases in Inflammatory Signalling and Inflammatory Bowel Disease by Liguo Zhu, Ying Li, Longyuan Zhou, Guang Yang, Ying Wang, Jing Han, Li Li, Shenghong Zhang

    Published 2020-01-01
    “…These processes also occur in autoimmune diseases, especially inflammatory bowel disease (IBD). To understand the importance of RING-type ligases in inflammation, we have discussed their functional mechanisms in multiple inflammation-associated pathways and correlation between RING-type ligases and IBD. …”
    Get full text
    Article
  5. 225
  6. 226

    Should My Patient with Inflammatory Bowel Disease on Immunosuppressive Therapy be Vaccinated against Influenza Virus? by Neeraj Narula, Deborah LR Yamamura, John K Marshall

    Published 2010-01-01
    “…Crohn’s disease and ulcerative colitis are variants of inflammatory bowel disease (IBD) for which immunosuppressive therapy is often required. …”
    Get full text
    Article
  7. 227

    Fecal microbiota transplantation: lights and shadows of a new weapon against inflammatory bowel disease by Andrea Piccioni, Federico Rosa, Federica Manca, Davide Antonio Della Polla, Martina Petrucci, Benedetta Simeoni, Marcello Covino

    Published 2023-03-01
    “…Treatment of inflammatory bowel disease (IBD) remains one of the most critical public health issues, mostly due to its wide global prevalence and dramatic impact on patients’ quality of life. …”
    Get full text
    Article
  8. 228

    Brain-Gut Interactions in Inflammatory Bowel Disease: Mechanisms of Anorexia in Animal Models of Experimental Colitis by Harvey P Weingarten

    Published 1996-01-01
    “…Elucidation of these gut-brain communication mechanisms is essential to the development of appropriate and efficacious treatments for the eating and weight disturbances associated with inflammatory bowel disease.…”
    Get full text
    Article
  9. 229
  10. 230
  11. 231

    Adherence to Azathioprine/6-Mercaptopurine in Children and Adolescents with Inflammatory Bowel Diseases: A Multimethod Study by Mervat M. Alsous, Ahmed F. Hawwa, Cameron Imrie, Andras Szabo, Eman Alefishat, Rana Abu Farha, Mohammad Rwalah, Rob Horne, James C. McElnay

    Published 2020-01-01
    “…The aim of this study was to investigate medication adherence in children with inflammatory bowel disease (IBD) utilizing a multimethod assessment approach. …”
    Get full text
    Article
  12. 232

    Paediatric Inflammatory Bowel Disease: A Mechanistic Approach to Investigate Exclusive Enteral Nutrition Treatment by Lily Nahidi, Andrew S. Day, Daniel A. Lemberg, Steven T. Leach

    Published 2014-01-01
    “…The inflammatory bowel diseases (IBD) include Crohn’s disease (CD) and ulcerative colitis. …”
    Get full text
    Article
  13. 233
  14. 234
  15. 235

    Age and Gender: Affecting the Positive Rates of Serum PAB and ANCA in Patients with Inflammatory Bowel Disease by Qingquan Chen, Shirong Huang, Yue Wu, Shuyu Zhang, Qicai Liu, Min Chen

    Published 2021-01-01
    “…Inflammatory bowel disease (IBD) is a group of immune-mediated conditions. …”
    Get full text
    Article
  16. 236

    The exercise-induced inflammatory response in inflammatory bowel disease: A systematic review and meta-analysis. by Kelly A Baker, Timothy D Miller, Frank E Marino, Tegan E Hartmann

    Published 2022-01-01
    “…<h4>Background</h4>This study investigated selected inflammatory responses to acute and chronic exercise in individuals with inflammatory bowel disease (IBD).<h4>Methods</h4>A systematic review and meta-analysis was conducted on all relevant exercise-based intervention publications with IBD participants. …”
    Get full text
    Article
  17. 237

    A Rare Form of Chronic Granulomatous Disease (Type Iva) Presenting as Inflammatory Bowel Disease by Francisco A Sylvester

    Published 1996-01-01
    “…Therefore it should be considered in the differential diagnosis of atypical inflammatory bowel disease, both in children and young adults.…”
    Get full text
    Article
  18. 238

    Depletion of key gut bacteria predicts disrupted bile acid metabolism in inflammatory bowel disease by Daniel Peterson, Christopher Weidenmaier, Sonia Timberlake, Rotem Gura Sadovsky

    Published 2025-02-01
    “…In particular, Inflammatory Bowel Disease (IBD) is characterized by a low concentration of secondary bile acids (SBAs), whose transformation from primary bile acids (PBAs) is an essential function performed solely by gut bacteria. …”
    Get full text
    Article
  19. 239

    Involvement of HLADQA1*05 in Patients with Inflammatory Bowel Disease Treated with Anti-TNF Drugs by Anna Pau, Ilaria Galliano, Elisa Barnini, Maddalena Dini, Antonio Pizzol, Alice Ponte, Stefano Gambarino, Pier Luigi Calvo, Massimiliano Bergallo

    Published 2025-01-01
    “…<i>Background</i>: Over the past decade, TNF inhibitors such as Infliximab and Adalimumab have become central to Inflammatory Bowel Diseases treatment, greatly enhancing patient outcomes. …”
    Get full text
    Article
  20. 240

    Differential pathological changes in colon microenvironments in acute and chronic mouse models of inflammatory bowel disease by NaYeon Ham, Minji Park, Young-An Bae, Eui-Ju Yeo, YunJae Jung

    Published 2025-12-01
    “…Inflammatory bowel disease is a chronic condition characterized by inflammation of the gastrointestinal tract, resulting from an abnormal immune response to normal stimuli, such as food and intestinal flora. …”
    Get full text
    Article